Thalidomide-NH-CH2-COOH is an innovative thalidomide derivative featuring a carboxylic acid functional group at the amino position, making it an optimal linker handle for PROTAC (Proteolysis Targeting Chimera) synthesis. As an E3 Ligase Ligand targeting cereblon (CRBN), this compound enables the development of targeted protein degraders by recruiting the CRBN E3 ubiquitin ligase complex. Ideal for use in academic research and drug discovery, Thalidomide-NH-CH2-COOH serves as a versatile building block for designing CRBN-based PROTACs and molecular glues with diverse target proteins and therapeutic applications.
Structure of 927670-97-1
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
Background Introduction
Thalidomide-NH-CH2-COOH is a thalidomide derivative specifically engineered for use in targeted protein degradation research. As a potent immunomodulatory imide drug (IMiD) analog, it acts as an efficient Cereblon (CRBN) E3 ligase ligand and is an integral component in Proteolysis Targeting Chimera (PROTAC) technologies. With the introduction of an amino-methylene-carboxyl linker at the 4-position, Thalidomide-NH-CH2-COOH provides a reactive and flexible carboxyl functionality for seamless conjugation and PROTAC construction, supporting advanced degrader design in drug discovery.
Mechanism
Thalidomide-NH-CH2-COOH operates by binding to the Cereblon (CRBN) subunit of the CUL4-CRBN E3 ubiquitin ligase complex. By serving as a high-affinity E3 ligase ligand, it enables the recruitment of CRBN to PROTAC molecules. When conjugated to a ligand for a protein of interest via its carboxyl-functionalized linker, it brings the E3 ligase in close proximity to the target protein, facilitating ubiquitination and subsequent proteasomal degradation. The NH-CH2-COOH linker ensures efficient and site-specific conjugation, supporting optimized PROTAC design and target engagement.
Applications
Thalidomide-NH-CH2-COOH is highly valued in the synthesis and optimization of CRBN-based PROTACs and molecular glue degraders. Its reactive carboxylic acid linker is ideal for coupling with diverse target protein ligands, enabling rapid development of bifunctional molecules for research and drug development. Key applications include:
• Construction of CRBN E3 ligase-recruiting segments in PROTAC synthesis
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.